Hideki Maeda

1.4k citations

102 papers · 1.1k indexed · h-index 17

Impact in

Cancer Research top 10%
- Cancer-related molecular mechanisms research
Clinical Biochemistry top 10%

Papers in ⓘ

Toxicology 4
Statistics and Probability 7
- Statistical Methods in Clinical Trials 7

Co-authors: Goro Kutomi (9 shared papers)Mitsuru Mori (5 shared papers)Haruo UZAWA (3 shared papers)Toshihiko Torigoe (3 shared papers)Kaori Takai (1 shared paper)Hiroeki Sahara (2 shared papers)Hiroto Ikeda (1 shared paper)Kenji Okita (1 shared paper)
Journals: Frontiers in Medicine (4 papers)Biological and Pharmaceutical Bulletin (3 papers)Clinical Pharmacology & Therapeutics (3 papers)International Journal of Clinical Oncology (3 papers)Japanese Journal of Clinical Oncology (3 papers)
Partner nations: Japan United States Germany

In The Last Decade

Hideki Maeda

90 papers receiving 1.0k citations

Peers

Countries citing papers authored by Hideki Maeda

Since Specialization

Citations

This map shows the geographic impact of Hideki Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Maeda more than expected).

Fields of papers citing papers by Hideki Maeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Maeda. The network helps show where Hideki Maeda may publish in the future.

Co-authors

The 25 scholars most cited alongside Hideki Maeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hideki Maeda Line = papers co-authored together Hideki Maeda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated Cancer Letters ·Atsushi Tanabe, Kenya Tanikawa, Mai Tsunetomi, Kaori Takai, Hiroto Ikeda, Junpei Konno, Toshihiko Torigoe, Hideki Maeda, Goro Kutomi, Kenji Okita, Mitsuru Mori, Hiroeki Sahara	2016	210
2	Discrimination of ethylene/vinyl acetate copolymers with different composition and prediction of the vinyl acetate content in the copolymers using Fourier-transform Raman spectroscopy and multivariate data analysis Vibrational Spectroscopy ·Masahiko Shimoyama, Hideki Maeda, K. Matsukawa, Hiroshi Inoue, T. Ninomiya, Yukihiro Ozaki	1997	63
3	Scavenger function of sinusoidal liver cells. Acetylated low-density lipoprotein is endocytosed via a route distinct from formaldehyde-treated serum albumin. Journal of Biological Chemistry ·Seikoh Horiuchi, K Takata, Hideki Maeda, Yoshimasa Morino	1985	57
4	TAT‐dextran–mediated mitochondrial transfer enhances recovery from models of reperfusion injury in cultured cardiomyocytes Journal of Cellular and Molecular Medicine ·Hideki Maeda, Daisuke Kami, Ryotaro Maeda, Yuki Murata, Jun‐ichiro Jo, Tomoya Kitani, Yasuhiko Tabata, Satoaki Matoba, Satoshi Gojo	2020	47
5	Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan? International Journal of Clinical Oncology ·Hideki Maeda, Tatsuo Kurokawa	2015	43
6	Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation. Journal of Lipid Research ·Hideki Maeda, Ryosuke Hashimoto, Teru Ogura, S Hiraga, Haruo UZAWA	1987	40
7	Inactivation of human placenta glutathione S-transferase by SHSS exchange reaction with biological disulfides Biochemical and Biophysical Research Communications ·Tsutomu Nishihara, Hideki Maeda, Kei-ichi Okamoto, Takuya Oshida, Tadashi Mizoguchi, Tomoyuki Terada	1991	39
8	Physical fitness Its contribution to serum high density lipoprotein Atherosclerosis ·Nobuhisa Nakamura, Haruo UZAWA, Hideki Maeda, Takeaki Inomoto	1983	38
9	Study on Human Erythrocyte Thioltransferase: Comparative Characterization with Bovine Enzyme and Its Physiological Role under Oxidative Stress The Journal of Biochemistry ·Tomoyuki Terada, Takuya Oshida, Masuhiro Nishimura, Hideki Maeda, Taizo Hara, Saburo Hosomi, Tadashi Mizoguchi, Tsutomu Nishihara	1992	38
10	Modulation of Glutathione S-Transferase Activity by a Thiol/Disulfide Exchange Reaction and Involvement of Thioltransferase Archives of Biochemistry and Biophysics ·T Terada, Hideki Maeda, Kota Okamoto, Tohru Nishinaka, Teruyasu Mizoguchi, Tatsuji Nishihara	1993	30
11	The Efficacy and Safety of Degarelix, a GnRH Antagonist: A 12-month, Multicentre, Randomized, Maintenance Dose-finding Phase II Study in Japanese Patients with Prostate Cancer Japanese Journal of Clinical Oncology ·S. Ozono, Takeshi Ueda, Senji Hoshi, Akito Yamaguchi, Hideki Maeda, Yusuke Fukuyama, Koji Takeda, Yasuo Ohashi, T. Tsukamoto, Seiji Naito, Hideyuki Akaza	2012	28
12	Direct and Indirect Actions of Dopamine on the Membrane Potential in Medium Spiny Neurons of the Mouse Neostriatum Journal of Neurophysiology ·Shingo Yasumoto, E. Tanaka, Gosuke Hattori, Hideki Maeda, H. Higashi	2002	26
13	High throughput single cell analysis of mitochondrial heteroplasmy in mitochondrial diseases Scientific Reports ·Ryotaro Maeda, Daisuke Kami, Hideki Maeda, Akira Shikuma, Satoshi Gojo	2020	22
14	Regulatory review time for approval of oncology drugs in Japan between 2001 and 2014. Considerations of changes, factors that affect review time, and difference with the United States The Journal of Clinical Pharmacology ·Hideki Maeda, Tatsuo Kurokawa	2015	21
15	Current status of the prognostic molecular biomarkers in breast cancer: A systematic review Oncology Letters ·Goro Kutomi, Toru Mizuguchi, Fukino Satomi, Hideki Maeda, Hiroaki Shima, Yasutoshi Kimura, Koichi Hirata	2017	19
16	Mechanisms Underlying the Enhancement of Excitatory Synaptic Transmission in Basolateral Amygdala Neurons of the Kindling Rat Journal of Neurophysiology ·Yoshihisa Shoji, E. Tanaka, Shigeyuki Yamamoto, Hideki Maeda, H. Higashi	1998	17
17	Differences in maximum tolerated doses and approval doses of molecularly targeted oncology drug between Japan and Western countries Investigational New Drugs ·Hideki Maeda, Tatsuo Kurokawa	2014	16
18	Acceptance of surrogate end points in clinical trials supporting approval of drugs for cancer treatment by the Japanese regulatory agency Annals of Oncology ·Hideki Maeda, Tomohiro Kurokawa	2014	15
19	Defect structure development in a pure iron and dilute iron alloys irradiated with neutrons and electrons Journal of Nuclear Materials ·Akira Okada, Hideki Maeda, K. Hamada, I. Ishida	1999	15
20	Association of plasma free-3-methoxy-4-hydroxyphenyl (ethylene)glycol, natural killer cell activity and delirium in postoperative patients International Clinical Psychopharmacology ·Jun Nakamura, Reiji Yoshimura, Tadao Okuno, N. Ueda, M Hachida, Kumiko Yasumoto, Hideaki Egami, Hideki Maeda, Motoi Nishi, Shinobu Aoyagi	2001	11

About Hideki Maeda

Hideki Maeda is a scholar working on Toxicology, Statistics and Probability, Economics and Econometrics, Cancer Research and Oncology, having authored 102 papers that have together received 1.1k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Economics and Policy (14 papers), Cancer Treatment and Pharmacology (7 papers), Statistical Methods in Clinical Trials (7 papers), Prostate Cancer Treatment and Research (6 papers), Biomedical Ethics and Regulation (6 papers), Economic and Financial Impacts of Cancer (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Cancer Research (213 citations), Clinical Biochemistry (55 citations), Molecular Biology (490 citations), Biophysics (30 citations) and Economics and Econometrics (133 citations). Hideki Maeda has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Goro Kutomi, Mitsuru Mori, Haruo UZAWA, Toshihiko Torigoe, Kaori Takai, Hiroeki Sahara, Hiroto Ikeda, Kenji Okita, Atsushi Tanabe and K Takata. Their work appears in journals such as Frontiers in Medicine, Biological and Pharmaceutical Bulletin, Clinical Pharmacology & Therapeutics, International Journal of Clinical Oncology and Japanese Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact